The Augment Bone Graft, based on recombinant human platelet-derived growth factor (rhPDGF-BB), was acquired from BioMimetic Therapeutics Inc. in March 2013. [See Deal] "It is a huge product. Al
Wright Medical Group NV overcame vendor quality challenges to gain FDA approval for its biologic-based Augment bone graft for aiding ankle/hindfoot fusion surgeries, opening up a $300 million US m
Wright Medical Group NV overcame vendor quality challenges to gain FDA approval for its biologic-based Augment bone graft for aiding ankle/hindfoot fusion surgeries, opening up a $300 million U.S.
FDA scrutiny of a component supplier continues to hold up Wright Medical Group NV 's path to approval for its Augment bone graft combination product. Augment gained an "approvable" letter last fa